Gabapentin Tablet
FDA Label NDC 70771-1916

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Gabapentin (NDC 70771-1916). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package Label.Principal Display Panel

NDC 70771-1861-9 in bottle of 90 tablets

Gabapentin tablets, 300 mg

Rx only

90 tablets

Gabapentin 300 mg (Dddcb2cc Bb94 4f75 87ed F7bf8c5db9b3 01)

Gabapentin 300 mg (Dddcb2cc Bb94 4f75 87ed F7bf8c5db9b3 01)

gabapentin 300 mg

NDC 70771-1862-9 in bottle of 90 tablets

Gabapentin tablets, 600 mg

Rx only

90 tablets

Gabapentin 600 mg (Dddcb2cc Bb94 4f75 87ed F7bf8c5db9b3 02)

Gabapentin 600 mg (Dddcb2cc Bb94 4f75 87ed F7bf8c5db9b3 02)

gabapentin 600 mg

* Please review the disclaimer below.